Tavist-D (clemastine fumarate 1.34 mg / phenylpropanolamine HCl 75 mg) 12HR Extended Release Oral Tablet
RxNorm 857413
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 857413 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tavist-D (clemastine fumarate 1.34 mg / phenylpropanolamine HCl 75 mg) 12HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
12 HR clemastine fumarate 1.34 mg / phenylpropanolamine hydrochloride 75 mg Extended Release Oral Tablet [Tavist-D]
(Atom ID: 12425558)
SY
Synonym (SY):
Tavist-D (clemastine fumarate 1.34 mg / phenylpropanolamine HCl 75 mg) 12 HR Extended Release Oral Tablet
(Atom ID: 12425560)
PSN